Can a simple drug make liver transplants safer?

NCT ID NCT07157631

Recruiting now Disease control Sponsor: RenJi Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a medicine called tranexamic acid can reduce blood loss during adult liver transplant surgery. About 1,546 people will be randomly assigned to receive either the drug or a placebo. The main goal is to see if the drug works better than placebo at controlling bleeding without increasing the risk of dangerous blood clots.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANEXAMIC ACID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure End Stage Liver Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END-STAGE LIVER DISEASE (ESLD) LIVER TRANSPLANTATION TRANEXAMIC ACID

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Anesthesiology, Renji Hospital, Shanghai Jiao Tong university school of medicine.
RECRUITING

Shanghai, Shanghai Municipality, 200123, China

Contact Phone: •••-•••-•••• Email: •••••@•••••